PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy

Biotech startup PANDA Therapeutics  https://www.venturekick.ch/panda-therapeutics has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new treatment for Alzheimer’s disease toward clinical development. By targeting multiple harmful protein deposits in the brain with a single therapy, the startup aims to improve treatment effectiveness and slow the progression of the disease. Alzheimer’s disease affects millions of people worldwide and places a growing burden on patients, families,